Depixus awarded a £600k grant from Innovate UK, the UK’s innovation agency

Read More

Depixus UK Ltd, has been awarded a £600k grant by Innovate UK, the UK’s innovation agency, for a project entitled “Complete nucleic acid analysis at genome scale with ultra-high throughput”.   This grant will support the development of one of Depixus’ key technology platforms, which is taking place at the company’s labs in Harston, Cambridgeshire.   Gordon Hamilton, Depixus’ CEO said…

Depixus’ CEO to present at the VIB conference: Revolutionizing Next-Generation Sequencing

Read More

Gordon Hamilton, CEO of Depixus will present the latest results from the company at the Revolutionizing Next-Generation Sequencing meeting, which will be held 25-26 March 2019, in Antwerp, Belgium in a talk entitled “Revealing the living genome: direct decoding of DNA, RNA and modified bases using Depixus’ novel technology.”   From the conference website: After two successful editions (Jan…

Depixus awarded a €2.05m grant through the EU’s H2020 SME Instrument Phase 2 programme

Read More

Depixus announced today that it has been awarded a €2.05m grant through the European Union’s prestigious H2020 SME Instrument Phase 2 programme.   The grant will fund an ambitious project to accelerate commercial development of high-throughput version of Depixus’ instrument system known as MAGNA Digital. This instrument system will be used to reveal important new layers of genetic…

Depixus named laureate in the final of France’s Worldwide Innovation Challenge

Read More

Depixus has been selected as one of only 12 laureates in the final phase of France’s ‘Concours Mondial de l’Innovation’ (Worldwide Innovation Challenge).   This is the culmination of the three rounds of competition, where over 2,000 companies that initially applied were whittled down to 12 laureates. Each of the companies will be eligible to receive up to €20m in financing from a dedicated…